Musolino Antonino and Campone Mario and Neven Patrick and Denduluri Neelima and Barrios Carlos H and Cortes Javier and Blackwell Kimberly and Soliman Hatem and Kahán Zsuzsanna and Bonnefoi Herve and Squires Matthew and Zhang Yong and Deudon Stephanie and Shi Michael M and Andre Fabrice:
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2(-) breast cancer that had progressed during or after prior endocrine therapy.
BREAST CANCER RESEARCH, 19.
ISSN 1465-5411
(2017)